Mineralys Therapeutics Ownership 2024 | Who Owns Mineralys Therapeutics Now?
Institutional Ownership
100.00%
Insider Ownership
2.55%
Retail Ownership
-2.55%
Institutional Holders
67.00
Mineralys Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
Tema ETF Trust | 1.25% | 55,806 | 37,335 | 202.13% | Feb 29, 2024 |
PRUDENTIAL SECTOR FUNDS, INC. | 0.12% | 242,942 | - | - | Feb 29, 2024 |
AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.06% | 626,053 | 242,334 | 63.15% | Jan 31, 2024 |
FRANKLIN STRATEGIC SERIES | 0.03% | 279,548 | 135,948 | 94.67% | Jan 31, 2024 |
FIDELITY ADVISOR SERIES VII | 0.02% | 206,422 | - | - | Jan 31, 2024 |
VANGUARD VALLEY FORGE FUNDS | 0.02% | 11,523 | - | - | Mar 31, 2024 |
ETFis Series Trust I | 0.01% | 9,947 | 3,742 | 60.31% | Jan 31, 2024 |
DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,031 | - | - | Mar 31, 2024 |
QUANTITATIVE MASTER SERIES LLC | 0.00% | 24,073 | - | - | Mar 31, 2024 |
DRIEHAUS MUTUAL FUNDS | 0.00% | 33,920 | - | - | Mar 28, 2024 |
FIDELITY SECURITIES FUND | 0.00% | 280,824 | - | - | Jan 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 852,912 | -159,883 | -15.79% | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 50,159 | 13,206 | 35.74% | Jan 31, 2024 |
Calvert Variable Products, Inc. | 0.00% | 1,872 | 900 | 92.59% | Mar 31, 2024 |
Managed Portfolio Series | 0.00% | 12,596 | - | - | Jan 31, 2024 |
Principal Exchange-Traded Funds | 0.00% | 6,002 | -381 | -5.97% | Mar 31, 2024 |
FIDELITY SELECT PORTFOLIOS | 0.00% | 29,900 | - | - | Feb 29, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 12,000 | -895 | -6.94% | Mar 31, 2024 |
AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 5,072 | 1,231 | 32.05% | Jan 31, 2024 |
VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 17,500 | - | - | Mar 31, 2024 |
Federated Hermes Global Allocation Fund | 0.00% | 3,224 | - | - | Feb 29, 2024 |
Federated Hermes Equity Funds | 0.00% | 6,000 | -14,000 | -70.00% | Mar 31, 2024 |
RBB FUND, INC. | 0.00% | 19,925 | - | - | Feb 29, 2024 |
Voya VARIABLE PORTFOLIOS INC | 0.00% | 6,450 | -1,097 | -14.54% | Mar 31, 2024 |
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 855 | - | - | Mar 31, 2024 |
Global X Funds | 0.00% | 5,236 | - | - | Jan 31, 2024 |
STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 6,200 | -4,000 | -39.22% | Mar 31, 2024 |
TIAA-CREF LIFE FUNDS | 0.00% | 215 | - | - | Mar 31, 2024 |
NORTHERN FUNDS | 0.00% | 7,831 | -1,429 | -15.43% | Mar 28, 2024 |
T. Rowe Price Index Trust, Inc. | 0.00% | 1,201 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 803,365 | -54,797 | -6.39% | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 48,590 | -33 | -0.07% | Mar 31, 2024 |
TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 10,103 | 10,103 | - | Feb 29, 2024 |
Fidelity Rutland Square Trust II | 0.00% | 38,040 | - | - | Feb 29, 2024 |
RYDEX SERIES FUNDS | 0.00% | 127 | - | - | Dec 31, 2023 |
ALLSPRING MASTER TRUST | 0.00% | 1,663 | - | - | Feb 29, 2024 |
RUSSELL INVESTMENT CO | 0.00% | 7,456 | - | - | Jan 31, 2024 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,270 | - | - | Mar 31, 2024 |
RYDEX DYNAMIC FUNDS | 0.00% | 63 | - | - | Dec 31, 2023 |
PENN SERIES FUNDS INC | 0.00% | 400 | - | - | Mar 28, 2024 |
ProFunds | 0.00% | 151 | -12 | -7.36% | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 2,526 | 461 | 22.32% | Jan 31, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 1,327 | 50 | 3.92% | Jan 31, 2024 |
TIAA-CREF FUNDS | 0.00% | 27,548 | 8,608 | 45.45% | Jan 31, 2024 |
Brighthouse Funds Trust II | 0.00% | 7,262 | - | - | Mar 31, 2024 |
RYDEX VARIABLE TRUST | 0.00% | 8 | - | - | Dec 31, 2023 |
COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 7,068 | - | - | Mar 31, 2024 |
Bridge Builder Trust | 0.00% | 29,885 | 310 | 1.05% | Mar 31, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 2,201 | 614 | 38.69% | Jan 31, 2024 |
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 11,700 | - | - | Mar 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 9,676 | -1,838 | -15.96% | Mar 31, 2024 |
FIDELITY SALEM STREET TRUST | 0.00% | 13,144 | 44 | 0.34% | Mar 31, 2024 |
PACIFIC SELECT FUND | 0.00% | 8,374 | -295 | -3.40% | Mar 31, 2024 |
Advisors' Inner Circle Fund III | 0.00% | 55 | 55 | - | Jan 31, 2024 |
BlackRock Variable Series Funds, Inc. | 0.00% | 2,022 | - | - | Mar 31, 2024 |
PRINCIPAL FUNDS, INC. | 0.00% | 2,283 | 478 | 26.48% | Jan 31, 2024 |
Mineralys Therapeutics's largest mutual fund holder by % of total assets is "Tema ETF Trust", owning 55.81K shares, compromising 1.25% of its total assets.
Mineralys Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 23 | 67 | - |
As of 31 Mar 23, 67 institutions are holding Mineralys Therapeutics's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 23 | 24,614,925 | - |
Mineralys Therapeutics (MLYS) has 24.61M shares outstanding as of 31 Mar 23, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 23 | 100.00% | - |
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 23 | - | - |
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 23 | - | - |
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 23 | 67 | - | 24,614,925 | - | 100.00% | - | - | - | - | - |
Mineralys Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
All Insider Owners Trades
The last insider sell of Mineralys Therapeutics's stock was made by Rodman David Malcom on Aug 13 2024, selling 6,348 shares at $1.08 per share (valued at $6.86K).
Mineralys Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 5 | 9 | 55.56% |
Q2 2024 | 15 | 15 | 100.00% |
Q1 2024 | 13 | 6 | 216.67% |
Q4 2023 | 4 | 3 | 133.33% |
Q3 2023 | 9 | 7 | 128.57% |
Q1 2023 | 11 | 7 | 157.14% |
5 total buy trades, and 9 total sell trades (buy/sell ratio of 0.56%) were made by Mineralys Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | 4 | - |
Q2 2024 | - | 8 | - |
Q1 2024 | 1 | - | - |
Q4 2023 | 1 | - | - |
Q3 2023 | 3 | 2 | 150.00% |
Q1 2023 | 3 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 4 open market sell trades of Mineralys Therapeutics's stocks.
MLYS Ownership FAQ
Who Owns Mineralys Therapeutics?
Mineralys Therapeutics is owned by institutional shareholders (100.00%), insiders (2.55%), and public (-2.55%). The largest institutional shareholder of Mineralys Therapeutics is (0% of total shares) and the top mutual fund owner is Tema ETF Trust (1.25% of total shares).
How many Mineralys Therapeutics shareholders are there?
As of Mar 2023, there are 67 institutional shareholders of Mineralys Therapeutics.